"Molecular Testing in Non-Small Cell Lung Cancer: An Overview and Update"

At the conclusion of this activity, the participant will be able to:

1.    Describe common and emerging predictive and prognostic molecular biomarkers for non-small cell lung cancer (NSCLC)
2.    Understand various molecular testing methodologies, especially next-generation sequencing, in NSCLC
3.    Discuss clinical utility and challenges of cell-free tumor DNA testing in NSCLC
 

plate with fork and knife, books, microscope and test tubes
Sponsor(s)
Medicine: Pathology
Speaker(s)
Zhongbo (Jerry) Yang, BM, Molecular Diagnostics Fellow, Department of Pathology
Audience
All ( Open to the public )